Brainsway Ltd - Asset Resilience Ratio

Latest as of September 2025: 0.95%

Brainsway Ltd (BWAY) has an Asset Resilience Ratio of 0.95% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Brainsway Ltd working capital to net assets to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

ILA1.08 Million
≈ $2.89K USD Cash + Short-term Investments

Total Assets

ILA113.06 Million
≈ $303.12K USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2012–2024)

This chart shows how Brainsway Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Brainsway Ltd asset portfolio.

Liquid Assets Composition Over Time

This chart breaks down Brainsway Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore long-term investment intensity of Brainsway Ltd to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents ILA0.00 0%
Short-term Investments ILA1.08 Million 0.95%
Total Liquid Assets ILA1.08 Million 0.95%

Asset Resilience Insights

  • Limited Liquidity: Brainsway Ltd maintains only 0.95% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Brainsway Ltd Industry Peers by Asset Resilience Ratio

Compare Brainsway Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
TransMedics Group Inc
NASDAQ:TMDX
Medical Devices 0.00%
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
Medical Devices 0.84%
Novocure Ltd
NASDAQ:NVCR
Medical Devices 43.72%
Shenzhen New Industries Biomedical
SHE:300832
Medical Devices 9.95%
Jafron Biomedical Co Ltd
SHE:300529
Medical Devices 34.37%
Hangzhou AGS MedTech Co. Ltd. A
SHG:688581
Medical Devices 18.80%
Nanjing Vishee Medical Technology Co Ltd
SHG:688580
Medical Devices 10.74%
Nanjing Medlander Medical Technology Co. Ltd. A
SHG:688273
Medical Devices 34.29%

Annual Asset Resilience Ratio for Brainsway Ltd (2012–2024)

The table below shows the annual Asset Resilience Ratio data for Brainsway Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 0.00% ILA0.00
≈ $0.00
ILA94.32 Million
≈ $252.86K
--
2023-12-31 56.32% ILA35.47 Million
≈ $95.08K
ILA62.97 Million
≈ $168.83K
+55.90pp
2022-12-31 0.42% ILA271.00K
≈ $726.54
ILA64.48 Million
≈ $172.86K
-52.96pp
2021-12-31 53.38% ILA40.43 Million
≈ $108.39K
ILA75.73 Million
≈ $203.03K
+52.73pp
2020-12-31 0.65% ILA221.00K
≈ $592.49
ILA34.01 Million
≈ $91.18K
+0.08pp
2019-12-31 0.57% ILA221.00K
≈ $592.49
ILA38.74 Million
≈ $103.85K
+0.14pp
2018-12-31 0.43% ILA101.00K
≈ $270.78
ILA23.60 Million
≈ $63.28K
+0.24pp
2017-12-31 0.18% ILA50.00K
≈ $134.05
ILA27.03 Million
≈ $72.47K
-2.75pp
2016-12-31 2.93% ILA585.00K
≈ $1.57K
ILA19.96 Million
≈ $53.52K
+0.30pp
2015-12-31 2.63% ILA585.00K
≈ $1.57K
ILA22.24 Million
≈ $59.63K
-1.56pp
2014-12-31 4.19% ILA1.08 Million
≈ $2.89K
ILA25.77 Million
≈ $69.09K
-3.98pp
2013-12-31 8.16% ILA1.46 Million
≈ $3.91K
ILA17.85 Million
≈ $47.85K
-37.63pp
2012-12-31 45.80% ILA4.89 Million
≈ $13.12K
ILA10.69 Million
≈ $28.65K
--
pp = percentage points

About Brainsway Ltd

TA:BWAY Israel Medical Devices
Market Cap
$422.69 Million
ILA157.66 Billion ILA
Market Cap Rank
#13157 Global
#139 in Israel
Share Price
ILA4020.00
Change (1 day)
-2.19%
52-Week Range
ILA2423.00 - ILA5074.00
All Time High
ILA5074.00
About

BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, East Asia, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, sc… Read more